References
- 1 . The state of innovation in drug development. Clin. Pharmacol. Ther. 83(2), 227–230 (2008).Crossref, Medline, CAS, Google Scholar
- 2 Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J. Med. Chem. 47(3), 550–557 (2004).Crossref, Medline, CAS, Google Scholar
- 3 . The glutamate receptor ion channels. Pharmacol. Rev. 51(1), 7–61 (1999).Medline, CAS, Google Scholar
- 4 . Non-competitive AMPA antagonists of 2,3-benzodiazepine type. Curr. Pharm. Des. 8(10), 913–939. (2002).Crossref, Medline, CAS, Google Scholar
- 5 . Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc. Natl Acad. Sci. USA 102(34), 12230–12235 (2005).Crossref, Medline, CAS, Google Scholar
- 6 Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454(7200), 118–121 (2008).Crossref, Medline, CAS, Google Scholar
- 7 . Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol. Scand. Suppl. 197, 19–24 (2013).Crossref, Medline, Google Scholar
- 8 Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. J. Neurosci. 17(16), 6179–6188 (1997).Crossref, Medline, CAS, Google Scholar
- 9 . Glutamate receptors: RNA editing and death of motor neurons. Nature 427(6977), 801 (2004).Crossref, Medline, CAS, Google Scholar
- 10 Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol. 18(1), 52–61 (2008).Crossref, Medline, Google Scholar
- 11 . RNA aptamers selected against the GluR2 glutamate receptor channel. Biochemistry 46(44), 12648–12655 (2007).Crossref, Medline, CAS, Google Scholar
- 12 . A single amino acid determines the subunit-specific spider toxin block of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor channels. Proc. Natl Acad. Sci. USA 90(14), 6528–6532. (1993).Crossref, Medline, CAS, Google Scholar
- 13 . Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists. Mini Rev. Med. Chem. 1(3), 243–253 (2001).Crossref, Medline, CAS, Google Scholar
- 14 . Mechanism of inhibition of the GluR2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives. Biochemistry 47(3), 1061–1069 (2008).Crossref, Medline, CAS, Google Scholar
- 15 . Mechanism of inhibition of GluA2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives: functional consequences of replacing a 7,8-methylenedioxy with a 7,8-ethylenedioxy moiety. Biochemistry 51(8), 1787–1795 (2012).Crossref, Medline, CAS, Google Scholar
- 16 . Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. ACS Chem. Neurosci. 5(2), 138–147 (2014).Crossref, Medline, CAS, Google Scholar
- 17 . Mechanism of inhibition of the GluA2 AMPA receptor channel opening by talampanel and its enantiomer: the stereochemistry of the 4-methyl group on the diazepine ring of 2,3-benzodiazepine derivatives. ACS Chem. Neurosci. 4(4), 635–644 (2013).Crossref, Medline, CAS, Google Scholar
- 18 . Advanced pharmacophore model of non-competitive AMPA antagonist 2,3-benzodiazepines. Lett. Drug Des. Discov. 1, 217–223 (2004).Crossref, CAS, Google Scholar
- 19 . An immunocytochemical study of the distribution of AMPA selective glutamate receptor subunits in the normal human motor system. Neuroscience 74(1), 185–198 (1996).Crossref, Medline, CAS, Google Scholar
- 20 . Potent and selective inhibition of a single alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit by an RNA aptamer. J. Biol. Chem. 286(17), 15608–15617 (2011).Crossref, Medline, CAS, Google Scholar

